- 167
- 12 107
International CML Foundation
United Kingdom
เข้าร่วมเมื่อ 26 ก.พ. 2023
The International CML Foundation (iCMLf) is on a mission to improve outcomes for patients with CML, globally.
Founded by a dedicated group of hematologists, we are committed to ensuring every patient with CML, no matter where they are in the world, receives the best possible care. We foster international collaboration to elevate knowledge, enhance diagnostics, and drive ground-breaking research.
As a charitable foundation with a global reach, we strive to empower physicians, researchers, patients and caregivers alike, in the collective pursuit of a cure.
Join us and contribute to a world where a cure for CML is not just a hope, but a reality.
Founded by a dedicated group of hematologists, we are committed to ensuring every patient with CML, no matter where they are in the world, receives the best possible care. We foster international collaboration to elevate knowledge, enhance diagnostics, and drive ground-breaking research.
As a charitable foundation with a global reach, we strive to empower physicians, researchers, patients and caregivers alike, in the collective pursuit of a cure.
Join us and contribute to a world where a cure for CML is not just a hope, but a reality.
Regional Discussion Group Africa 25th Sept 24 Pt 1 of 2: Anticipating & managing acute TKI toxicity
Anticipating and managing acute TKI toxicity and adverse events
Presenter
Dr Amma Anima Benneh-Akwasi Kuma
University of Ghana Medical School and
Ghana Institute of Clinical Genetics
Accra, Ghana
Expert Panel
Dr Valentin Garcia Gutierrez
Hospital Universitario Ramon y Cajal,
Universidad de Alcala
Madrid, Spain
Professor Gianantonio Rosti
IRCCS/SIRHHC Scientific Institute for Research,
Hospitalisation and Health Care
Meldola (FC), Italy
Dr Ephrem Haile
Addis Ababa University,
Addis Ababa, Ethiopia
Pour voir cette vidéo avec traduction française: th-cam.com/video/i3IADqoRN70/w-d-xo.html
This presentation was part of our first African Regional Discussion Group for 2024.
To see part 2 (The realities of long-term treatment - managing the chronic effects of TKIs, chronic complications and other challenges) go here: th-cam.com/video/FSy2hqwdLMM/w-d-xo.html
Presenter
Dr Amma Anima Benneh-Akwasi Kuma
University of Ghana Medical School and
Ghana Institute of Clinical Genetics
Accra, Ghana
Expert Panel
Dr Valentin Garcia Gutierrez
Hospital Universitario Ramon y Cajal,
Universidad de Alcala
Madrid, Spain
Professor Gianantonio Rosti
IRCCS/SIRHHC Scientific Institute for Research,
Hospitalisation and Health Care
Meldola (FC), Italy
Dr Ephrem Haile
Addis Ababa University,
Addis Ababa, Ethiopia
Pour voir cette vidéo avec traduction française: th-cam.com/video/i3IADqoRN70/w-d-xo.html
This presentation was part of our first African Regional Discussion Group for 2024.
To see part 2 (The realities of long-term treatment - managing the chronic effects of TKIs, chronic complications and other challenges) go here: th-cam.com/video/FSy2hqwdLMM/w-d-xo.html
มุมมอง: 9
วีดีโอ
Regional Discussion Group Africa 25th Sept 24 Pt 2 of 2: Realities of long-term treatment
มุมมอง 117 ชั่วโมงที่ผ่านมา
Realities of long-term treatment: Managing chronic TKI effects, complications & other challenges Presenter Dr Ephrem Haile Addis Ababa University, Addis Ababa, Ethiopia Expert Panel Dr Valentin Garcia Gutierrez Hospital Universitario Ramon y Cajal, Universidad de Alcala Madrid, Spain Professor Gianantonio Rosti IRCCS/SIRHHC Scientific Institute for Research, Hospitalisation and Health Care Meld...
Anticiper et gérer la toxicité aiguë des ITK et les événements indésirables
มุมมอง 57 ชั่วโมงที่ผ่านมา
Présentatrice Dr Amma Anima Benneh-Akwasi Kuma University of Ghana Medical School and Ghana Institute of Clinical Genetics Accra, Ghana Experts Dr Valentin Garcia Gutierrez Hospital Universitario Ramon y Cajal, Universidad de Alcala Madrid, Spain Professor Gianantonio Rosti IRCCS/SIRHHC Scientific Institute for Research, Hospitalisation and Health Care Meldola (FC), Italy Dr Ephrem Haile Addis ...
Réalités du traitement à long terme : effets chroniques des ITK, les complications et autres défis
มุมมอง 47 ชั่วโมงที่ผ่านมา
Présentateur : Dr Ephrem Haile Addis Ababa University, Addis Ababa, Ethiopia Groupe d'experts : Dr Valentin Garcia Gutierrez Hospital Universitario Ramon y Cajal, Universidad de Alcala Madrid, Spain Professor Gianantonio Rosti IRCCS/SIRHHC Scientific Institute for Research, Hospitalisation and Health Care Meldola (FC), Italy Dr Amma Anima Benneh-Akwasi Kuma University of Ghana Medical School an...
World CML Day: A special message from Chairman Jorge Cortes
มุมมอง 280วันที่ผ่านมา
The theme for this year’s CML day is‘Building Bridges, Leave No Patient Behind’, shining a light on the disparities that still exist in access to CML care. For many individuals and communities around the world obstacles such as late diagnosis, inadequate treatment, and limited support remain significant challenges. Please watch this special message from iCMLf Chairman Professor Jorge Cortes and...
Secuenciación del tratamiento con TKI y manejo de los efectos crónicos del tratamiento con TKI
มุมมอง 184หลายเดือนก่อน
To view this video in the original English, click here: th-cam.com/video/4056-8mUETg/w-d-xo.html Para ver este vídeo con traducción al portugués, haga clic aquí: th-cam.com/video/OTbslHmIuvs/w-d-xo.html Expertas regionales: Dr Lilian Pilleux Universidad Austral de Chile and Valdivia Hospital Valdivia, Chile Dr Katia Pagnano Centro de Hematologia e Hemoterapia (HEMOCENTRO) Universidade Estadual ...
Regional Discussion Group July 2024 - Latin America - TKI Sequencing and Managing Chronic Effects
มุมมอง 59หลายเดือนก่อน
TKI Sequencing of Treatment, and Managing Chronic Effects of TKI Treatment Para ver este video con traducción al español, haga clic aquí: th-cam.com/video/-2Zgt_kKnzQ/w-d-xo.html Para ver este vídeo con traducción al portugués, haga clic aquí: th-cam.com/video/OTbslHmIuvs/w-d-xo.html Regional Experts: Dr Lilian Pilleux Universidad Austral de Chile and Valdivia Hospital Valdivia, Chile Dr Katia ...
CML Highlights of EHA 2024 - Biological overview
มุมมอง 1592 หลายเดือนก่อน
Professor Nick Cross Professor of Human Genetics at the University of Southampton Southampton (UK) 00:00 Introduction Prediction of DMR/TFR 01:17 Abstract S167: A novel immune-related score predicts deep molecular response in chronic-phase CML treated upfront with TKIs 03:19 Abstract S166: A machine-learning approach identifies a 27-genes transcriptome signature predicting TFR in CML 05:32 Abst...
CML Highlights of EHA 2024 - Clinical overview
มุมมอง 1692 หลายเดือนก่อน
Professor Andreas Hochhaus Director of the Department of Hematology and Medical Oncology Jena University Hospital (Germany) 00:00 Welcome and introduction 02:01 Treatment optimisation in CML (Hochhaus EHA 2024) 03:25 Line-agnostic treatment recommendations according to clinical and biological data 04:38 Asciminib first-line ASC4 First (Hochhaus et al, EHA 2024) 09:21 Dasatinib dose optimisation...
Regional Discussion Group - June 24 - Latin America: TFR vs Dose Reduction
มุมมอง 742 หลายเดือนก่อน
In the first of our Latin America Regional Discussion Groups for 2024 we debate whether TFR or dose reduction is the better pathway to stopping therapy. Experts: Dr Virginia Abello Polo Center for Cancer Treatment and Research Luis Carlos Sarmiento Angulo Foundation, Bogota, Colombia Professor Ehab Atallah Hematologic Malignancies Division of Hematology & Oncology, Medical College of Wisconsin,...
Regional Discussion Group June 24 South Asia 3 of 3 - When & How to Set Up High Quality Testing Labs
มุมมอง 543 หลายเดือนก่อน
iCMLf Regional Discussion Group 26 June 2024: South Asia 2023 ELN laboratory recommendations - Challenges in low- and middle-income countries When and How to Set Up High-Quality Testing Laboratories when Resources are Limited Part 3 of 3 Presenter: Professor Deepak Kumar Mishra TATA Medical Center, Kolkata, India Regional Experts: Dr Zeeshan Ansar Ahmed The Aga Khan University Karachi, Pakistan...
Regional Discussion Group June 24 South Asia 2 of 3 - When and How to look for BCR::ABL1 Mutations
มุมมอง 403 หลายเดือนก่อน
iCMLf Regional Discussion Group 26 June 2024: South Asia 2023 ELN laboratory recommendations - Challenges in low- and middle-income countries When and How to look for BCR::ABL1 Mutations Part 2 of 3 Presenter: Dr Zeeshan Ansar Ahmed The Aga Khan University Karachi, Pakistan Regional Experts: Dr Mohammad Ali National Institute of Cancer Research and Hospital Mohakhali, Dhaka, Bangladesh Professo...
Regional Discussion Group June 24 South Asia 1 of 3 - BCR::ABL1 Testing
มุมมอง 373 หลายเดือนก่อน
iCMLf Regional Discussion Group 26 June 2024: South Asia 2023 ELN laboratory recommendations - Challenges in low- and middle-income countries BCR::ABL1 Testing - When and How to Test When Resources are Limited Part 1 of 3 Presenter: Dr Mohammad Ali National Institute of Cancer Research and Hospital Mohakhali, Dhaka, Bangladesh Regional Experts: Dr Zeeshan Ansar Ahmed The Aga Khan University Kar...
Regional Discussion Group 29 May 2024 South Asia 2 of 2 - The Role of Allogenic Stem Cell Transplant
มุมมอง 523 หลายเดือนก่อน
Experts: Professor Sadashivudu Gundeti Nizam's Institute of Medical Sciences Hyderabad, India Professor Naeem Chaudhri King Faisal Specalist Hospital and Research Centre Riyadh, Saudi Arabia 00:00 Introduction 00:44 Case 1: Difficulty finding matched donor and resource constraints 04:51 Discussion of Case 1 17:22 Case 2: Transplant for a drug-resistant mutation 22:37 Discussion of case 2 33:22 ...
Regional Discussion Group 29 May 2024 South Asia 1 of 2 - The Realities of Long-Term Treatment
มุมมอง 913 หลายเดือนก่อน
Regional Discussion Group 29 May 2024 South Asia 1 of 2 - The Realities of Long-Term Treatment
Annapurna 2023: What the iCMLf Did Next…
มุมมอง 494 หลายเดือนก่อน
Annapurna 2023: What the iCMLf Did Next…
South Asian Regional Discussion Group April 24, 2024
มุมมอง 1484 หลายเดือนก่อน
South Asian Regional Discussion Group April 24, 2024
CML Highlights of ASH 2023 - Biological overview
มุมมอง 1.5K7 หลายเดือนก่อน
CML Highlights of ASH 2023 - Biological overview
CML Highlights of ASH 2023 - Clinical overview
มุมมอง 4727 หลายเดือนก่อน
CML Highlights of ASH 2023 - Clinical overview
Interview Timothy Hughes and Jorge Cortes
มุมมอง 1158 หลายเดือนก่อน
Interview Timothy Hughes and Jorge Cortes
Challenging Scenario 7: 53yo male with atypical CML
มุมมอง 548 หลายเดือนก่อน
Challenging Scenario 7: 53yo male with atypical CML
Challenging Scenario 5: 29yo male lost to treatment and returns in blast crisis. SCT not available
มุมมอง 248 หลายเดือนก่อน
Challenging Scenario 5: 29yo male lost to treatment and returns in blast crisis. SCT not available
Challenging Scenario 6: 37yo female with poor compliance, multiple TKI failure, taken to transplant
มุมมอง 378 หลายเดือนก่อน
Challenging Scenario 6: 37yo female with poor compliance, multiple TKI failure, taken to transplant
Challenging Scenario 4: Managing lack of compliance and loss of response
มุมมอง 188 หลายเดือนก่อน
Challenging Scenario 4: Managing lack of compliance and loss of response
Challenging Scenario 3: 47yo male with drug-related toxicities including thrombocytopenia
มุมมอง 298 หลายเดือนก่อน
Challenging Scenario 3: 47yo male with drug-related toxicities including thrombocytopenia
Challenging Scenario 2: 69yo male with TKI resistance and intolerance
มุมมอง 398 หลายเดือนก่อน
Challenging Scenario 2: 69yo male with TKI resistance and intolerance
Challenging Scenario 1: 24yo male in blast crisis at presentation
มุมมอง 728 หลายเดือนก่อน
Challenging Scenario 1: 24yo male in blast crisis at presentation
Where can I download the presentation files from the video?
sir good morning can i join in your foundation. im a cml diagnosed last dec. 2023 from phil..im now maintaining medicine imatinib 400mg per day
Hello doctor In your conclusion you dont mention the difference of e13 vs e14 transcript and also the influence of age. Is there a reason ?
Promo-SM 😇
Sir l want to be a oncholgy doctor. My sister is a cancer patient. now l am studying in Navodaya vidyalaya